Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Complications of Congenital Hernia in Pregnancy: A Case Report.

Vasquez DN, Basualdo MN, Aphalo VM, Carreras LP, Plotnikow GA, Intile AD, Moreira J.

A A Pract. 2019 Aug 1;13(3):102-106. doi: 10.1213/XAA.0000000000001004.

PMID:
30920425
2.

Halogen bonding effects on the outcome of reactions at metal centres.

Carreras L, Benet-Buchholz J, Franconetti A, Frontera A, van Leeuwen PWNM, Vidal-Ferran A.

Chem Commun (Camb). 2019 Feb 19;55(16):2380-2383. doi: 10.1039/c8cc08884e.

PMID:
30729960
3.

High-flow nasal cannula in the treatment of acute hypoxemic respiratory failure in a pregnant patient: case report.

Plotnikow GA, Vasquez D, Pratto R, Carreras L.

Rev Bras Ter Intensiva. 2018 Oct-Dec;30(4):508-511. doi: 10.5935/0103-507X.20180072. Spanish, English.

4.

XBphos-Rh: a halogen-bond assembled supramolecular catalyst.

Carreras L, Serrano-Torné M, van Leeuwen PWNM, Vidal-Ferran A.

Chem Sci. 2018 Feb 19;9(15):3644-3648. doi: 10.1039/c8sc00233a. eCollection 2018 Apr 21.

5.

Synthesis and biological evaluation of N,N'-squaramides with high in vivo efficacy and low toxicity: toward a low-cost drug against Chagas disease.

Olmo F, Rotger C, Ramírez-Macías I, Martínez L, Marín C, Carreras L, Urbanová K, Vega M, Chaves-Lemaur G, Sampedro A, Rosales MJ, Sánchez-Moreno M, Costa A.

J Med Chem. 2014 Feb 13;57(3):987-99. doi: 10.1021/jm4017015. Epub 2014 Jan 22.

PMID:
24410674
6.

Molecular recognition of zwitterions: enhanced binding and selective recognition of miltefosine by a squaramide-based host.

López C, Sanna E, Carreras L, Vega M, Rotger C, Costa A.

Chem Asian J. 2013 Jan;8(1):84-7. doi: 10.1002/asia.201200881. Epub 2012 Nov 5. No abstract available.

PMID:
23129548
7.

[Economic and epidemiologic aspects of generalized anxiety disorder: a review of the literature].

Albarracin G, Rovira J, Carreras L, Rejas J.

Actas Esp Psiquiatr. 2008 May-Jun;36(3):165-76. Review. Spanish.

8.

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.

Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, Carreras L, Arranz EA, Garrido CA, López-Trascasa M, Sánchez-Corral P, Morgan BP, Rodríguez de Córdoba S.

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):240-5. Epub 2006 Dec 20. Erratum in: Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10749.

9.

Renal involvement in non-malignant IgM gammopathy.

Ramos R, Poveda R, Sarrá J, Domingo A, Carreras L, Grinyó JM.

Nephrol Dial Transplant. 2007 Feb;22(2):627-30. Epub 2006 Dec 12. No abstract available.

PMID:
17164317
10.

Attempts to make sense of the antiphospholipid syndrome.

Vermylen J, Carreras LO, Arnout J.

J Thromb Haemost. 2007 Jan;5(1):1-4. Epub 2006 Oct 5.

11.

Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.

Esparza-Gordillo J, Jorge EG, Garrido CA, Carreras L, López-Trascasa M, Sánchez-Corral P, de Córdoba SR.

Mol Immunol. 2006 Apr;43(11):1769-75. Epub 2006 Jan 18.

12.

Thrombotic thrombocytopenic purpura with severe large artery branch involvement.

Ibernon M, Moreso F, Carreras L, Carrera M, Serrano T, Rama I, Bestard O, Torras J, Poveda R, Grinyó JM.

Nephrol Dial Transplant. 2005 Feb;20(2):467-8. No abstract available.

PMID:
15673703
13.

Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome.

Pelegri Y, Cerrato G, Martinuzzo ME, Carreras LO, Forastiero RR.

Clin Exp Rheumatol. 2003 Mar-Apr;21(2):221-4.

PMID:
12747279
14.

Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.

Martinuzzo ME, de Larrañaga GF, Forastiero RR, Pelegri Y, Fariña MH, Alonso BS, Kordich LC, Carreras LO.

Clin Exp Rheumatol. 2002 Jul-Aug;20(4):477-83.

PMID:
12175102
15.

Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

Carreras L, Poveda R, Bas J, Mestre M, Rama I, Carrera M.

Am J Kidney Dis. 2002 May;39(5):E21.

PMID:
11979333
16.

Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism.

Varela ML, Adamczuk YP, Forastiero RR, Martinuzzo ME, Cerrato GS, Pombo G, Carreras LO.

Thromb Res. 2001 Dec 1;104(5):317-24.

PMID:
11738073
17.

Imbalance towards Th2-type response in patients with definite primary antiphospholipid syndrome.

Forastiero R, Martinuzzo M, Carreras LO.

Thromb Haemost. 2001 Sep;86(3):934-5. No abstract available.

PMID:
11583333
19.

Thrombophilic factors in chronic thromboembolic pulmonary hypertension.

Colorio CC, Martinuzzo ME, Forastiero RR, Pombo G, Adamczuk Y, Carreras LO.

Blood Coagul Fibrinolysis. 2001 Sep;12(6):427-32.

PMID:
11555695
20.

The combination of thrombophilic genotypes is associated with definite antiphospholipid syndrome.

Forastiero R, Martinuzzo M, Adamczuk Y, Varela ML, Pombo G, Carreras LO.

Haematologica. 2001 Jul;86(7):735-41.

21.

Evaluation of red blood cell aggregation in diabetes by computerized image analysis.

Foresto P, D'Arrigo M, Carreras L, Cuezzo RE, Valverde J, Rasia R.

Medicina (B Aires). 2000;60(5 Pt 1):570-2.

PMID:
11188894
22.

High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity.

de Larrañaga GF, Forastiero RR, Martinuzzo ME, Carreras LO, Tsariktsian G, Sturno MM, Alonso BS.

Lupus. 2000;9(8):594-600.

PMID:
11035434
23.

Which are the best biological markers of the antiphospholipid syndrome?

Carreras LO, Forastiero RR, Martinuzzo ME.

J Autoimmun. 2000 Sep;15(2):163-72. Review.

PMID:
10968904
24.

Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population.

Adamczuk Y, Iglesias Varela ML, Forastiero R, Martinuzzo M, Cerrato G, Pombo G, Carreras LO.

Thromb Haemost. 2000 Mar;83(3):509-10. No abstract available.

PMID:
10744162
25.

Early occlusion of coronary by-pass associated with the presence of factor V Leiden and the prothrombin 20210A allele: case report.

Varela ML, Adamczuk YP, Martinuzzo ME, Forastiero RR, Klein FR, Rossi AS, Carreras LO.

Blood Coagul Fibrinolysis. 1999 Oct;10(7):443-6.

PMID:
10695772
26.

Occurrence of anti-prothrombin and anti-beta2-glycoprotein I antibodies in patients with history of thrombosis.

Forastiero R, Martinuzzo M, Adamczuk Y, Carreras LO.

J Lab Clin Med. 1999 Dec;134(6):610-5.

PMID:
10595789
27.

Binding properties of antibodies to prothrombin and beta2-glycoprotein I (beta2-GPI) assayed by ELISA and dot blot.

Forastiero RR, Martinuzzo ME, Carreras LO.

Clin Exp Immunol. 1999 Dec;118(3):480-6.

28.

Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome.

de Larrañaga GF, Forastiero RR, Carreras LO, Alonso BS.

Thromb Res. 1999 Oct 1;96(1):19-25.

PMID:
10554081
29.

Antiplatelet factor 4--heparin antibodies in patients with antiphospholipid antibodies.

Martinuzzo ME, Forastiero RR, Adamczuk Y, Pombo G, Carreras LO.

Thromb Res. 1999 Sep 15;95(6):271-9.

PMID:
10527404
30.

[Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction].

Forastiero RR, Martinuzzo ME, Carreras LO.

Sangre (Barc). 1999 Jun;44(3):223-30. Review. Spanish. No abstract available.

PMID:
10481585
31.

Cholesterol embolism associated with macroscopic renal infarction.

Ramos R, Cruzado JM, Palom X, Poveda R, Carreras L, Grinyó JM, Alsina J.

Nephrol Dial Transplant. 1999 Apr;14(4):962-5. No abstract available.

PMID:
10328481
32.

Acquired hypoprothrombinemia related to high titres of antiprotein-phospholipid antibodies.

de Larrañaga G, Forastiero R, Carreras LO, Zala N, Guzman L, Alonso B.

Thromb Haemost. 1999 Feb;81(2):317-8. No abstract available.

PMID:
10064016
33.

Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.

Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO.

J Rheumatol. 1998 Jul;25(7):1313-9.

PMID:
9676762
34.

[Moderate hyperhomocysteinemia: physiopathology of the endothelial lesion and its clinical implications].

Falcón CR, Carreras LO.

Sangre (Barc). 1998 Feb;43(1):47-54. Review. Spanish. No abstract available.

PMID:
9577181
36.

Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.

Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO.

Thromb Haemost. 1997 Sep;78(3):1008-14.

PMID:
9308745
37.

Pregnancy loss and autoantibodies against phospholipid-binding proteins.

Falcón CR, Martinuzzo ME, Forastiero RR, Cerrato GS, Carreras LO.

Obstet Gynecol. 1997 Jun;89(6):975-80.

PMID:
9170477
38.

[Role of fibrinogen in arterial vascular pathology].

Colorio CC, Falcón CR, Carreras LO.

Sangre (Barc). 1997 Feb;42(1):47-52. Review. Spanish. No abstract available.

PMID:
9097719
39.

Familial hemolytic uremic syndrome: simulation linkage analysis.

Carreras L, Volpini V, Poveda R, Fernández Robres A, Alsina J.

Contrib Nephrol. 1997;122:196-9. No abstract available.

PMID:
9399066
40.

Pathogenic role of antiprotein-phospholipid antibodies.

Carreras LO, Forastiero RR.

Haemostasis. 1996 Oct;26 Suppl 4:340-57. Review.

PMID:
8979139
41.

Activated protein C resistance in patients with anti-beta 2 glycoprotein I antibodies.

Martinuzzo M, Forastiero R, Adamczuk Y, Cerrato G, Carreras LO.

Blood Coagul Fibrinolysis. 1996 Oct;7(7):702-4.

PMID:
8958393
42.

Antiphospholipid antibodies, eicosanoids and expression of endothelial cyclooxygenase-2.

Carreras LO, Martinuzzo ME, Maclouf J.

Lupus. 1996 Oct;5(5):494-7. Review. No abstract available.

PMID:
8902789
43.

Increased plasma thrombomodulin in different subgroups of patients with antiphospholipid and anti beta(2) glycoprotein I antibodies.

Martinuzzo ME, Forastiero RR, Carreras LO.

Thromb Haemost. 1996 Jun;75(6):972-3. No abstract available.

PMID:
8822596
44.

Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis.

Forastiero RR, Martinuzzo ME, Kordich LC, Carreras LO.

Thromb Haemost. 1996 May;75(5):717-20.

PMID:
8725711
45.

[Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].

Blejer JL, Saguier MC, Salamone HJ, Carreras LA.

Sangre (Barc). 1995 Dec;40(6):447-51. Spanish.

PMID:
8850226
46.

Interstitial nephritis in sarcoidosis: simultaneous multiorgan involvement.

Cruzado JM, Poveda R, Mañá J, Carreras L, Carrera M, Grinyó JM, Alsina J.

Am J Kidney Dis. 1995 Dec;26(6):947-51.

PMID:
7503070
47.

Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies.

Habib A, Martinuzzo ME, Carreras LO, Lévy-Toledano S, Maclouf J.

Thromb Haemost. 1995 Aug;74(2):770-7.

PMID:
8585020
48.

[Therapeutic immunoadsorption in Goodpasture disease].

Moreso F, Poveda R, Gil-Vernet S, Carreras L, García-Osuna R, Griñó JM, Alsina J.

Med Clin (Barc). 1995 Jun 10;105(2):59-61. Spanish.

PMID:
7603097
49.

[Use of aprotinin in cardiovascular surgery].

Colorio C, Carreras LO.

Sangre (Barc). 1995 Jun;40(3):207-11. Review. Spanish. No abstract available.

PMID:
7570273
50.

Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis.

Martinuzzo ME, Forastiero RR, Carreras LO.

Br J Haematol. 1995 Feb;89(2):397-402.

PMID:
7873391

Supplemental Content

Loading ...
Support Center